MPD: Measures involving CC

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Brinkmeyer1:1	Brinkmeyer1	body weight	Theiler's murine encephalomyelitis virus	body weight, post infection [g] bw 64401 day 0 day 2 day 4 day 6 day 8 day 10 day 14 day 17 day 22 day 27 day 30 day 34 day 45 day 60 day 75 day 87	CC	5	both	4wks	N=5	2017

Brinkmeyer1:17	Brinkmeyer1	health assessment	Theiler's murine encephalomyelitis virus	clinical score (0=normal, 6=moribund), post infection [score] clin_score 64417 day 0 day 2 day 4 day 6 day 8 day 12 day 18 day 24 day 29 day 34 day 42 day 46 day 68 day 75 day 82 day 87	CC	5	both	4wks	N=5	2017

Brinkmeyer1:33	Brinkmeyer1	RNA expression profiling	Theiler's murine encephalomyelitis virus	TMEV transcript abundance (normalized), post infection TMEV 64433 day 7 day 28	CC	4	both	4wks	N=1	2017

Brinkmeyer1:35	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of seconds spent grooming, 10 min test, post infection wk 3 (manual assessment) [s] grooming 64435	CC	5	both	4wks	N=2	2017

Brinkmeyer1:36	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of times mouse reared, 10 min test, post infection wk 3 (manual assessment) [n] activity_rearing 64436	CC	5	both	4wks	N=2	2017

Brinkmeyer1:37	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	horizontal movement latency, 30 min test, post infection wk 3 [s] horiz_latency 64437 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:39	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of horizontal movements (beam breaks), 30 min test, post infection wk 3 [n] horiz_activity 64439 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:41	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	horizontal distance traveled, 30 min test, post infection wk 3 [cm] horiz_distance 64441 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:43	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent moving horizontally, 30 min test, post infection wk 3 [s] horiz_time 64443 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:45	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	horizontal movement velocity, 30 min test, post infection wk 3 [cm/s] horiz_velocity 64445 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:47	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of vertical plane entries, 30 min test, post infection wk 3 [n] vert_activity 64447 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:49	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of vertical plane episodes, 30 min test, post infection wk 3 [n] vert_episodes 64449 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:51	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent vertical, 30 min test, post infection wk 3 [s] vert_time 64451 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:53	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent resting, 30 min test, post infection wk 3 [s] resting 64453 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:55	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of center entries, 30 min test, post infection wk 3 [n] center_entries 64455 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:57	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent in center, 30 min test, post infection wk 3 [s] center_time 64457 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:59	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent in periphery, 30 min test, post infection wk 3 [s] periphery_time 64459 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:61	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of steps included in analysis as measured by DigiGait, post infection day 27, forelimb [n] num_steps_fore 64461 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:63	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of steps included in analysis as measured by DigiGait, post infection day 27, hindlimb [n] num_steps_hind 64463 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:65	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, forelimb [s] swing_dur_fore 64465 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:67	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, hindlimb [s] swing_dur_hind 64467 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:69	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, forelimb [%] swing_stride_fore 64469 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:71	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, hindlimb [%] swing_stride_hind 64471 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:73	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of braking phase as measured by DigiGait, post infection day 27, forelimb [s] brake_dur_fore 64473 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:75	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of braking phase as measured by DigiGait, post infection day 27, hindlimb [s] brake_dur_hind 64475 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:77	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stride_fore 64477 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:79	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stride_hind 64479 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:81	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stance_fore 64481 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:83	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stance_hind 64483 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:85	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of propulsion phase as measured by DigiGait, post infection day 27, forelimb [s] propel_dur_fore 64485 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:87	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of propulsion phase as measured by DigiGait, post infection day 27, hindlimb [s] propel_dur_hind 64487 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:89	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stride_fore 64489 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:91	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stride_hind 64491 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:93	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stance_fore 64493 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:95	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stance_hind 64495 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:97	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, forelimb [%] stance_stride_fore 64497 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:99	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, hindlimb [%] stance_stride_hind 64499 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:101	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, forelimb [ratio] stance_swing_fore 64501 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:103	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, hindlimb [ratio] stance_swing_hind 64503 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:105	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, forelimb [s] stride_dur_fore 64505 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:107	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, hindlimb [s] stride_dur_hind 64507 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:109	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, forelimb [n/s] stride_freq_fore 64509 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:111	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, hindlimb [n/s] stride_freq_hind 64511 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:113	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_fore 64513 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:115	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_hind 64515 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:117	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length variability as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_var_fore 64517 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:119	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length variability as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_var_hind 64519 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:121	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length coefficient of variation as measured by DigiGait, post infection day 27, forelimb [%] stride_length_CV_fore 64521 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:123	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length coefficient of variation as measured by DigiGait, post infection day 27, hindlimb [%] stride_length_CV_hind 64523 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:125	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_fore 64525 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:127	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_hind 64527 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:129	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_SD_fore 64529 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:131	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_SD_hind 64531 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:133	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal paw area as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_max_fore 64533 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:135	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal paw area as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_max_hind 64535 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:137	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_SD_fore 64537 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:139	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_SD_hind 64539 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:141	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of forelimb stepping to fore limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, forelimb [ratio] gait_symmetry_fore 64541 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:143	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of forelimb stepping to hind limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, hindlimb [ratio] gait_symmetry_hind 64543 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:145	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_break_fore 64545 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:147	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_break_hind 64547 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:149	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_propuls_fore 64549 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:151	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_propuls_hind 64551 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:153	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, forelimb [cm] overlap_distance_fore 64553 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:155	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, hindlimb [cm] overlap_distance_hind 64555 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:157	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, forelimb [cm] paw_placement_fore 64557 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:159	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, hindlimb [cm] paw_placement_hind 64559 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:161	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	gait variability metric as measured by DigiGait, post infection day 27, forelimb ataxia_coefficient_fore 64561 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:163	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	gait variability metric as measured by DigiGait, post infection day 27, hindlimb ataxia_coefficient_hind 64563 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:165	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] midline_distance_fore 64565 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:167	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] midline_distance_hind 64567 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:169	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] axis_distance_fore 64569 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:171	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] axis_distance_hind 64571 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:173	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	perpendicular distance between centroids of either set of axial paws during peak stance as measured by DigiGait, post infection day 27 [cm] stance_width 64573 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:175	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stance width coefficient of variation as measured by DigiGait, post infection day 27 [%] stance_width_CV 64575 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:177	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of left and right stance durations as measured by DigiGait, post infection day 27 [ratio] stance_factor 64577 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:179	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride width variability as measured by DigiGait, post infection day 27 [cm] stride_width_var 64579 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:181	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle made between left and right paws as a function of stride length and stance width as measured by DigiGait, post infection day 27 [deg] step_angle 64581 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:183	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	step angle variability (standard deviation of step angle for set of strides recorded) as measured by DigiGait, post infection day 27 [deg] step_angle_SD 64583 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:185	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	step angle coefficient of variation as measured by DigiGait, post infection day 27 [%] step_angle_CV 64585 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:187	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	length of forelimb steps as measured by foot print analysis, post infection [cm] length_fore 64587 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:194	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	width of forelimb steps as measured by foot print analysis, post infection [cm] width_fore 64594 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:201	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	length of hindlimb steps as measured by foot print analysis, post infection [cm] length_hind 64601 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:208	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	width of hindlimb steps as measured by foot print analysis, post infection [cm] width_hind 64608 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:215	Brinkmeyer1	rotarod	Theiler's murine encephalomyelitis virus	time to fall from accelerating rotarod, post infection wk 7 [s] rotarod 64615 trial 1 trial 2 trial 3 trial 4 trial 5 trial 6 trial 7 trial 8 trial 9	CC	5	both	4wks	N=2	2017

JaxCC1:9001	JaxCC1	open field test	(none)	whole arena time spent mobile, 20 min test [s] time_mobile_OF 89001	CC	18	both	7-9wks	N=7	2018

JaxCC1:9002	JaxCC1	open field test	(none)	whole arena resting time, 20 min test [s] whole_rest_OF 89002	CC	18	both	7-9wks	N=7	2018

JaxCC1:9003	JaxCC1	open field test	(none)	whole arena time spent vertical, 20 min test [s] time_vertical_OF 89003	CC	17	both	7-9wks	N=7	2018

JaxCC1:9004	JaxCC1	open field test	(none)	number of rears, 20 min test [n] rears_OF 89004 1st 5min 2nd 5min 3rd 5min 4th 5min	CC	17	both	7-9wks	N=7	2018

JaxCC1:9008	JaxCC1	open field test	(none)	total number of rears, 20 min test [n] rears_total_OF 89008	CC	17	both	7-9wks	N=7	2018

JaxCC1:9009	JaxCC1	open field test	(none)	distance traveled [cm] distance_OF 89009 1st 5min 2nd 5min 3rd 5min 4th 5min	CC	18	both	7-9wks	N=7	2018

JaxCC1:9013	JaxCC1	open field test	(none)	total distance traveled, 20 min test [cm] distance_total_OF 89013	CC	18	both	7-9wks	N=7	2018

JaxCC1:9014	JaxCC1	open field test	(none)	distance traveled habituation ratio, 20 min test [ratio] distance_habit__OF 89014	CC	18	both	7-9wks	N=7	2018

JaxCC1:9015	JaxCC1	open field test	(none)	distance traveled slope, 20 min test distance_slope_OF 89015	CC	18	both	7-9wks	N=7	2018

JaxCC1:9016	JaxCC1	open field test	(none)	distance traveled in center of arena, 20 min test [cm] center_dist_OF 89016	CC	18	both	7-9wks	N=7	2018

JaxCC1:9017	JaxCC1	open field test	(none)	distance traveled in periphery of arena, 20 min test [cm] periphery_dist_OF 89017	CC	18	both	7-9wks	N=7	2018

JaxCC1:9018	JaxCC1	open field test	(none)	average speed in center of arena, 20 min test [cm/s] center_speed_OF 89018	CC	18	both	7-9wks	N=7	2018

JaxCC1:9019	JaxCC1	open field test	(none)	average speed in periphery of arena, 20 min test [cm/s] periphery_speed_OF 89019	CC	18	both	7-9wks	N=7	2018

JaxCC1:9020	JaxCC1	open field test	(none)	whole arena average speed, 20 min test [cm/s] whole_speed_OF 89020	CC	18	both	7-9wks	N=7	2018

JaxCC1:9025	JaxCC1	open field test	(none)	number of fecal boli, 20 min test [n] defecation_OF 89025	CC	18	both	7-9wks	N=7	2018

JaxCC1:9028	JaxCC1	open field test	(none)	permanence time in periphery of arena, 20 min test [s] periphery_perm_OF 89028	CC	18	both	7-9wks	N=7	2018

JaxCC1:9030	JaxCC1	open field test	(none)	permanence time in corners of arena, 20 min test [s] corners_perm_OF 89030	CC	18	both	7-9wks	N=7	2018

JaxCC1:9031	JaxCC1	open field test	(none)	percentage of total time in corners of arena, 20 min test [s] pct_corners_OF 89031	CC	18	both	7-9wks	N=7	2018

JaxCC1:9032	JaxCC1	open field test	(none)	percentage of total time in corners, habituation ratio, 20 min test [%] pct_corners_habit_OF 89032	CC	18	both	7-9wks	N=7	2018

JaxCC1:9033	JaxCC1	open field test	(none)	percentage of total time in corners, slope, 20 min test pct_corners_slope_OF 89033	CC	18	both	7-9wks	N=7	2018

JaxCC1:9036	JaxCC1	open field test	(none)	permanence time in center of arena, 20 min test [s] center_perm_OF 89036	CC	18	both	7-9wks	N=7	2018

JaxCC1:9038	JaxCC1	open field test	(none)	percentage of total time in center of arena, 20 min test [%] pct_center_OF 89038	CC	18	both	7-9wks	N=7	2018

JaxCC1:9039	JaxCC1	open field test	(none)	percentage of total time in center, habituation ratio, 20 min test [ratio] pct_center_habit_OF 89039	CC	18	both	7-9wks	N=7	2018

JaxCC1:9040	JaxCC1	open field test	(none)	percentage of total time in center of arena, slope, 20 min test pct_center_slope_OF 89040	CC	18	both	7-9wks	N=7	2018

JaxCC1:9046	JaxCC1	body weight	(none)	body weight [g] bw_abr 89046	CC	18	both	15-17wks	N=3	2017

JaxCC1:9047	JaxCC1	ABR test	(none)	auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 89047 6kHz pip 12kHz pip 18kHz pip 24kHz pip 30kHz pip	CC	18	both	15-17wks	N=3	2017

JaxCC1:9056	JaxCC1	hole board test	(none)	number of hole pokes, 20 min test [n] hole_pokes 89056	CC	7	both	8-9wks	N=5	2017

JaxCC1:9061	JaxCC1	acoustic startle test	(none)	average acoustic startle response (ASR) evoked by background noise [amplitude] ASR_BN 89061	CC	18	both	9-11wks	N=7	2017

JaxCC1:9062	JaxCC1	acoustic startle test	(none)	average acoustic startle response (ASR), adjusted for background noise [amplitude] ASR 89062 sound pressure level: 74dB 78dB 82dB 120dB	CC	18	both	9-11wks	N=7	2017

JaxCC1:9071	JaxCC1	acoustic startle test	(none)	average percent prepulse inhibition (PPI) evoked by 120 dB, adjusted for background noise [%] PPI 89071 prepulse stimulus: 74dB 78dB 82dB	CC	18	both	9-11wks	N=7	2017

JaxCC1:9076	JaxCC1	acoustic startle test	(none)	average percent prepulse inhibition (PPI) evoked by global prepulse stimulus (74, 78, 82 dB), adjusted for background noise [%] PPI_global 89076	CC	18	both	9-11wks	N=7	2017

JaxCC1:9078	JaxCC1	acoustic startle test	(none)	maximum slope for percent prepulse inhibition (PPI) averages (74, 78, 82 dB), adjusted for background noise PPI_slope 89078	CC	18	both	9-11wks	N=7	2017

JaxCC1:9086	JaxCC1	light-dark box	(none)	latency to enter dark zone, 20 min test [s] reaction_time_LD 89086	CC	18	both	8-10wks	N=7	2017

JaxCC1:9087	JaxCC1	light-dark box	(none)	time mobile in light zone, 20 min test [s] light_mobile_LD 89087	CC	18	both	8-10wks	N=7	2017

JaxCC1:9088	JaxCC1	light-dark box	(none)	time mobile in dark zone, 20 min test [s] dark_mobile_LD 89088	CC	18	both	8-10wks	N=7	2017

JaxCC1:9089	JaxCC1	light-dark box	(none)	time spent in light zone, 20 min test [s] light_dur_LD 89089	CC	18	both	8-10wks	N=7	2017

JaxCC1:9090	JaxCC1	light-dark box	(none)	time spent in dark zone, 20 min test [s] dark_dur_LD 89090	CC	18	both	8-10wks	N=7	2017

JaxCC1:9091	JaxCC1	light-dark box	(none)	percentage of total time in light zone, 20 min test [%] pct_light_LD 89091	CC	18	both	8-10wks	N=7	2017

JaxCC1:9092	JaxCC1	light-dark box	(none)	percentage of total time in dark zone, 20 min test [%] pct_dark_LD 89092	CC	18	both	8-10wks	N=7	2017

JaxCC1:9093	JaxCC1	light-dark box	(none)	number of transitions between light and dark zones, 20 min test [n] transitions_LD 89093	CC	18	both	8-10wks	N=7	2017

JaxCC1:9094	JaxCC1	light-dark box	(none)	fecal boli count, 20 min test [n] defecation_LD 89094	CC	18	both	8-10wks	N=7	2017

JaxCC1:9095	JaxCC1	body weight	(none)	body weight [g] bw_griptest 89095	CC	18	both	7-9wks	N=7	2017

JaxCC1:9096	JaxCC1	grip strength	(none)	forelimb grip strength [g] front_paws 89096 trial1 trial2 trial3	CC	18	both	7-9wks	N=7	2017

JaxCC1:9099	JaxCC1	grip strength	(none)	forelimb grip strength [g] front_paws_summ 89099 average average normalized to bw	CC	18	both	7-9wks	N=7	2017

JaxCC1:9106	JaxCC1	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws 89106 trial1 trial2 trial3	CC	18	both	7-9wks	N=7	2017

JaxCC1:9109	JaxCC1	grip strength	(none)	forelimb and hindlimb grip strength [g] all_paws_summ 89109 average average normalized to bw	CC	18	both	7-9wks	N=7	2017

JaxCC1:9113	JaxCC1	ECG	(none)	heart rate (beats per min) [n/min] HR 89113	CC	18	both	10-12wks	N=7	2017

JaxCC1:9114	JaxCC1	ECG	(none)	heart rate variability, mean of differences between sequential beats (beats per min) [n/min] HR_V 89114	CC	18	both	10-12wks	N=7	2017

JaxCC1:9115	JaxCC1	ECG	(none)	heart rate coefficient of variation (signal intensity) [%] HR_CV 89115	CC	18	both	10-12wks	N=7	2017

JaxCC1:9116	JaxCC1	ECG	(none)	duration of RR interval [ms] RR 89116	CC	18	both	10-12wks	N=7	2017

JaxCC1:9117	JaxCC1	ECG	(none)	duration of PQ interval [ms] PQ 89117	CC	18	both	10-12wks	N=7	2017

JaxCC1:9118	JaxCC1	ECG	(none)	duration of PR interval [ms] PR 89118	CC	18	both	10-12wks	N=7	2017

JaxCC1:9119	JaxCC1	ECG	(none)	duration of QRS interval [ms] QRS 89119	CC	18	both	10-12wks	N=7	2017

JaxCC1:9120	JaxCC1	ECG	(none)	duration of QT interval [ms] QT 89120	CC	18	both	10-12wks	N=7	2017

JaxCC1:9121	JaxCC1	ECG	(none)	duration of ST interval [ms] ST 89121	CC	18	both	10-12wks	N=7	2017

JaxCC1:9122	JaxCC1	ECG	(none)	duration of QTC interval, calculated by dividing QT interval by square root of preceding RR interval [ms] QTc 89122	CC	18	both	10-12wks	N=7	2017

JaxCC1:9123	JaxCC1	ECG	(none)	QT dispersion, measured as inter-lead variability of QT intervals [ms] QT_dispersion 89123	CC	18	both	10-12wks	N=7	2017

JaxCC1:9124	JaxCC1	ECG	(none)	QTc dispersion, calculated as rate-corrected QT dispersion [ms] QTc_dispersion 89124	CC	18	both	10-12wks	N=7	2017

JaxCC1:9125	JaxCC1	ECG	(none)	mean SR amplitude, mean amplitude of signal measured from signal minimum line to peak of QRS [mV] SR_amplitude 89125	CC	18	both	10-12wks	N=7	2017

JaxCC1:9126	JaxCC1	ECG	(none)	mean R amplitude, mean amplitude of signal measured from isoelectric line to peak of QRS [mV] R_amplitude 89126	CC	18	both	10-12wks	N=7	2017

JaxCC1:9127	JaxCC1	ECG	(none)	root mean square of successive differences of neighboring RR intervals [ms] rMSSD 89127	CC	18	both	10-12wks	N=7	2017

JaxCC1:9128	JaxCC1	ECG	(none)	proportion of number of pairs of successive beat-to-beat intervals that exceed 50 ms (6>ms) [%] pNN50 89128	CC	18	both	10-12wks	N=2	2017

JaxCC1:9134	JaxCC1	tail suspension test	(none)	latency to immobility, 5 min test [s] immob_latency_TS 89134	CC	14	both	10-12wks	N=7	2018

JaxCC1:9135	JaxCC1	tail suspension test	(none)	duration of immobility, 5 min test [s] immob_duration_TS 89135	CC	14	both	10-12wks	N=7	2018

JaxCC1:9139	JaxCC1	rotarod	(none)	duration [s] duration 89139	CC	18	both	10-12wks	N=7	2018

JaxCC1:9141	JaxCC1	rotarod	(none)	mean duration on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] duration_rota 89141	CC	18	both	10-12wks	N=7	2018

JaxCC1:9142	JaxCC1	rotarod	(none)	learning difference on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] learn_diff_rota 89142	CC	18	both	10-12wks	N=7	2018

JaxCC1:9143	JaxCC1	rotarod	(none)	learning slope on accelerating rotarod (4-40 rpm/5 min) over 5 trials learn_slope_rota 89143	CC	18	both	10-12wks	N=7	2018

JaxCC1:9151	JaxCC1	urinalysis	(none)	glucose (urine GLU) [mg/dL] urine_GLU 89151	CC	14	both	12-13wks	N=5	2017

JaxCC1:9152	JaxCC1	urinalysis	(none)	magnesium level (urine Mg) [mg/dL] urine_Mg 89152	CC	13	both	12-13wks	N=5	2017

JaxCC1:9153	JaxCC1	urinalysis	(none)	creatinine (urine CREA) [mg/dL] CREA 89153	CC	14	both	12-13wks	N=5	2017

JaxCC1:9154	JaxCC1	urinalysis	(none)	microalbumin (urine MA), calculated [mg/dL] MA 89154	CC	14	both	12-13wks	N=5	2017

JaxCC1:9155	JaxCC1	urinalysis	(none)	albumin-creatinine ratio (urine ACR) [mg/g] ACR 89155	CC	14	both	12-13wks	N=5	2017

JaxCC1:9160	JaxCC1	DXA	(none)	percent fat, whole body scan, head excluded [%] pct_fat 89160	CC	18	both	13-15wks	N=7	2017

JaxCC1:9161	JaxCC1	DXA	(none)	fat tissue mass, head excluded [g] fat 89161	CC	18	both	13-15wks	N=7	2017

JaxCC1:9162	JaxCC1	DXA	(none)	fat tissue mass to body weight ratio [ratio] fat_adj 89162	CC	18	both	13-15wks	N=7	2017

JaxCC1:9163	JaxCC1	DXA	(none)	lean tissue mass of whole body scan, head excluded [g] lean 89163	CC	18	both	13-15wks	N=7	2017

JaxCC1:9164	JaxCC1	DXA	(none)	lean tissue mass to body weight ratio [ratio] lean_adj 89164	CC	18	both	13-15wks	N=7	2017

JaxCC1:9165	JaxCC1	DXA	(none)	total tissue mass, whole body scan, head excluded [g] TTM 89165	CC	18	both	13-15wks	N=7	2017

JaxCC1:9169	JaxCC1	DXA	(none)	bone mineral content of whole body scan, head excluded [g] BMC 89169	CC	18	both	13-15wks	N=7	2017

JaxCC1:9170	JaxCC1	DXA	(none)	bone mineral content to body weight ratio [ratio] BMC_adj 89170	CC	18	both	13-15wks	N=7	2017

JaxCC1:9171	JaxCC1	DXA	(none)	bone mineral density of whole body scan, head excluded [g/cm²] BMD 89171	CC	18	both	13-15wks	N=7	2017

JaxCC1:9172	JaxCC1	DXA	(none)	bone area, whole body, head excluded [cm²] bone_area 89172	CC	18	both	13-15wks	N=7	2017

JaxCC1:9173	JaxCC1	body size and weight	(none)	body weight [g] bw_dxa 89173	CC	18	both	13-15wks	N=7	2017

JaxCC1:9174	JaxCC1	body size and weight	(none)	body length [cm] body_length 89174	CC	18	both	13-15wks	N=7	2017

JaxCC1:9179	JaxCC1	metabolic panel	(none)	total bilirubin (plasma TBIL) [mg/dL] TBIL 89179	CC	18	both	17-19wks	N=6	2017

JaxCC1:9180	JaxCC1	metabolic panel	(none)	calcium (plasma Ca) [mg/dL] calcium 89180	CC	18	both	17-19wks	N=6	2017

JaxCC1:9181	JaxCC1	metabolic panel	(none)	chloride (plasma Cl) [mmol/L] chloride 89181	CC	18	both	17-19wks	N=6	2017

JaxCC1:9182	JaxCC1	metabolic panel	(none)	iron (plasma Fe) [mg/dL] iron 89182	CC	18	both	17-19wks	N=6	2017

JaxCC1:9183	JaxCC1	metabolic panel	(none)	phosphorus (plasma phosphate) [mg/dL] phosphate 89183	CC	18	both	17-19wks	N=6	2017

JaxCC1:9184	JaxCC1	metabolic panel	(none)	potassium (plasma K) [mmol/L] potassium 89184	CC	18	both	17-19wks	N=6	2017

JaxCC1:9185	JaxCC1	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP 89185	CC	18	both	17-19wks	N=6	2017

JaxCC1:9186	JaxCC1	metabolic panel	(none)	sodium (plasma Na) [mmol/L] sodium 89186	CC	18	both	17-19wks	N=6	2017

JaxCC1:9187	JaxCC1	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 89187	CC	18	both	17-19wks	N=6	2017

JaxCC1:9188	JaxCC1	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST 89188	CC	18	both	17-19wks	N=6	2017

JaxCC1:9189	JaxCC1	metabolic panel	(none)	aspartate transaminase to alanine transaminase ratio (plasma AST:ALT) [ratio] AST_ALT_ratio 89189	CC	18	both	17-19wks	N=6	2017

JaxCC1:9190	JaxCC1	metabolic panel	(none)	carbon dioxide (plasma CO₂) [mmol/L] carbon_dioxide 89190	CC	18	both	17-19wks	N=6	2017

JaxCC1:9191	JaxCC1	metabolic panel	(none)	glucose (plasma GLU, no fast) [mg/dL] GLU 89191	CC	18	both	17-19wks	N=6	2017

JaxCC1:9192	JaxCC1	metabolic panel	(none)	albumin (plasma Alb) [g/L] albumin 89192	CC	18	both	17-19wks	N=6	2017

JaxCC1:9194	JaxCC1	metabolic panel	(none)	total protein (plasma TP) [g/L] total_protein 89194	CC	18	both	17-19wks	N=6	2017

JaxCC1:9195	JaxCC1	metabolic panel	(none)	blood urea nitrogen (BUN) [mg/dL] urea 89195	CC	18	both	17-19wks	N=5	2017

JaxCC1:9196	JaxCC1	lipid profile	(none)	HDL cholesterol (plasma HDL) [mg/dL] HDL 89196	CC	18	both	17-19wks	N=6	2017

JaxCC1:9197	JaxCC1	lipid profile	(none)	HDL cholesterol to total cholesterol ratio [ratio] HDL_total_ratio 89197	CC	18	both	17-19wks	N=6	2017

JaxCC1:9198	JaxCC1	lipid profile	(none)	total cholesterol (plasma CHOL, no fast) [mg/dL] CHOL 89198	CC	18	both	17-19wks	N=6	2017

JaxCC1:9199	JaxCC1	lipid profile	(none)	non-esterified fatty acids (plasma NEFA) [mmol/L] NEFA 89199	CC	18	both	17-19wks	N=5	2017

JaxCC1:9200	JaxCC1	lipid profile	(none)	triglyceride (plasma TG, no fast) [mg/dL] TG 89200	CC	18	both	17-19wks	N=6	2017

JaxCC1:9201	JaxCC1	hormone quantification	(none)	insulin (plasma) [pg/mL] insulin 89201	CC	18	both	17-19wks	N=6	2017

JaxCC1:9206	JaxCC1	complete blood count	(none)	red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 89206	CC	18	both	17-19wks	N=6	2017

JaxCC1:9207	JaxCC1	complete blood count	(none)	reticulocyte count (Retic; units per volume x 10⁹) [n/µL] Retic 89207	CC	18	both	17-19wks	N=6	2017

JaxCC1:9208	JaxCC1	complete blood count	(none)	reticulocyte differential (percent of total RBC) [%] pct_Retic 89208	CC	18	both	17-19wks	N=6	2017

JaxCC1:9209	JaxCC1	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 89209	CC	18	both	17-19wks	N=6	2017

JaxCC1:9210	JaxCC1	complete blood count	(none)	basophil differential (percent of total WBC) [%] pct_BASO 89210	CC	18	both	17-19wks	N=6	2017

JaxCC1:9211	JaxCC1	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] pct_EOS 89211	CC	18	both	17-19wks	N=6	2017

JaxCC1:9212	JaxCC1	complete blood count	(none)	lymphocyte differential (percent of total WBC) [%] pct_LYM 89212	CC	18	both	17-19wks	N=6	2017

JaxCC1:9213	JaxCC1	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO 89213	CC	18	both	17-19wks	N=6	2017

JaxCC1:9214	JaxCC1	complete blood count	(none)	neutrophil differential (percent of total WBC) [%] pct_NEUT 89214	CC	18	both	17-19wks	N=6	2017

JaxCC1:9215	JaxCC1	complete blood count	(none)	large unstained cells (percent of total WBC) [%] pct_LUC 89215	CC	18	both	17-19wks	N=6	2017

JaxCC1:9219	JaxCC1	complete blood count	(none)	hematocrit (HCT) [%] HCT 89219	CC	18	both	17-19wks	N=6	2017

JaxCC1:9220	JaxCC1	complete blood count	(none)	measured hemoglobin (mHGB) [g/dL] mHGB 89220	CC	18	both	17-19wks	N=6	2017

JaxCC1:9221	JaxCC1	complete blood count	(none)	calculated hemoglobin (cHGB) [g/dL] cHGB 89221	CC	18	both	17-19wks	N=6	2017

JaxCC1:9222	JaxCC1	complete blood count	(none)	RBC corpuscular hemoglobin concentration mean (CHCM) [g/dL] CHCM 89222	CC	18	both	17-19wks	N=6	2017

JaxCC1:9223	JaxCC1	complete blood count	(none)	mean corpuscular hemoglobin (CHr) [pg] CHr 89223	CC	18	both	17-19wks	N=6	2017

JaxCC1:9224	JaxCC1	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 89224	CC	18	both	17-19wks	N=6	2017

JaxCC1:9225	JaxCC1	complete blood count	(none)	mean RBC corpuscular hemoglobin (MCH) [pg] MCH 89225	CC	18	both	17-19wks	N=6	2017

JaxCC1:9226	JaxCC1	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 89226	CC	18	both	17-19wks	N=6	2017

JaxCC1:9229	JaxCC1	complete blood count	(none)	RBC corpuscular distribution width (RDW) [%] RDW 89229	CC	18	both	17-19wks	N=6	2017

JaxCC1:9230	JaxCC1	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 89230	CC	18	both	17-19wks	N=6	2017

JaxCC1:9231	JaxCC1	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] PLT 89231	CC	18	both	17-19wks	N=6	2017

JaxCC1:9232	JaxCC1	complete blood count	(none)	mean platelet volume (MPV) [fL] MPV 89232	CC	18	both	17-19wks	N=6	2017

JaxCC1:9236	JaxCC1	body weight	(none)	body weight [g] bw 89236	CC	18	both	17-19wks	N=6	2017

JaxCC1:9237	JaxCC1	organ weights	(none)	heart weight [mg] heart_wt 89237 weight normalized to body weight	CC	18	both	17-19wks	N=6	2017

Lazear1:1	Lazear1	organ weights	(none)	testis weight (1 testis) [g] testis_wt 63101	CC	12	m	15-22wks	N=2	2018

Lazear1:2	Lazear1	sperm count	(none)	number of sperm per mL of semen (x 10⁶) [n/mL] sperm_count 63102	CC	10	m	15-22wks	N=2	2018

Lazear1:3	Lazear1	microscopy	(none)	percentage of sperm that are motile [%] sperm_motile 63103	CC	10	m	15-22wks	N=2	2018

Lazear1:4	Lazear1	microscopy	(none)	percentage of sperm that move in a consistent direction [%] sperm_processive 63104	CC	10	m	15-22wks	N=2	2018

Lazear1:5	Lazear1	colony observation	(none)	mean litter size after mating with two FVB/NJ females [n] litter_size 63105	CC	10	m	15-22wks	N=1	2018

Lesage1:1	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3- [%] CD3_neg 63501	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:2	Lesage1	immune cell quantification	(none)	percentage of splenic CD3- lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_CD3_neg 63502	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:3	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_tot 63503	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:4	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27- CD11b- [%] CD27_neg_CD11b_neg 63504	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:5	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27+ CD11b- [%] CD27_pos_CD11b_neg 63505	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:6	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27+ CD11b+ [%] CD27_pos_CD11b_pos 63506	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:7	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27- CD11b+ [%] CD27_neg_CD11b_pos 63507	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:8	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_NK 63508	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:9	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_tot 63509	CC w/par	64	both	5-8wks	N=2	2018

Lesage1:10	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:11	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:12	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:13	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:14	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:15	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are T cells [%] T_cells 63515	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:16	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:17	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:18	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:19	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:20	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:21	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:22	Lesage1	immune cell quantification	(none)	ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522	CC w/par	65	both	5-8wks	N=2	2018

Lesage1:23	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are plasmacytoid dendritic cells [%] pDC 63523	CC w/par	63	both	5-8wks	N=2	2018

Lesage1:24	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are conventional dendritic cells [%] cDC 63524	CC w/par	63	both	5-8wks	N=2	2018

Lesage1:25	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are merocytic [%] mDC_of_cDC 63525	CC w/par	63	both	5-8wks	N=2	2018

Lesage1:26	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are merocytic dendritic cells [%] mDC_of_tot 63526	CC w/par	63	both	5-8wks	N=2	2018

Lesage1:27	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are cDC1 [%] cDC1_of_cDC 63527	CC w/par	63	both	5-8wks	N=2	2018

Lesage1:28	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are cDC1 conventional dendritic cells [%] cDC1_of_tot 63528	CC w/par	63	both	5-8wks	N=2	2018

Lesage1:29	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are cDC2 [%] cDC2_of_cDC 63529	CC w/par	63	both	5-8wks	N=2	2018

Brinkmeyer1

body weight

Theiler's murine encephalomyelitis virus

body weight, post infection [g] bw 64401 day 0 day 2 day 4 day 6 day 8 day 10 day 14 day 17 day 22 day 27 day 30 day 34 day 45 day 60 day 75 day 87

CC

5

both

4wks

N=5

2017

Brinkmeyer1

health assessment

Theiler's murine encephalomyelitis virus

clinical score (0=normal, 6=moribund), post infection [score] clin_score 64417 day 0 day 2 day 4 day 6 day 8 day 12 day 18 day 24 day 29 day 34 day 42 day 46 day 68 day 75 day 82 day 87

CC

5

both

4wks

N=5

2017

Brinkmeyer1

RNA expression profiling

Theiler's murine encephalomyelitis virus

TMEV transcript abundance (normalized), post infection TMEV 64433 day 7 day 28

CC

4

both

4wks

N=1

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of seconds spent grooming, 10 min test, post infection wk 3 (manual assessment) [s] grooming 64435

CC

5

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of times mouse reared, 10 min test, post infection wk 3 (manual assessment) [n] activity_rearing 64436

CC

5

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

horizontal movement latency, 30 min test, post infection wk 3 [s] horiz_latency 64437 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of horizontal movements (beam breaks), 30 min test, post infection wk 3 [n] horiz_activity 64439 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

horizontal distance traveled, 30 min test, post infection wk 3 [cm] horiz_distance 64441 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent moving horizontally, 30 min test, post infection wk 3 [s] horiz_time 64443 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

horizontal movement velocity, 30 min test, post infection wk 3 [cm/s] horiz_velocity 64445 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of vertical plane entries, 30 min test, post infection wk 3 [n] vert_activity 64447 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of vertical plane episodes, 30 min test, post infection wk 3 [n] vert_episodes 64449 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent vertical, 30 min test, post infection wk 3 [s] vert_time 64451 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent resting, 30 min test, post infection wk 3 [s] resting 64453 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of center entries, 30 min test, post infection wk 3 [n] center_entries 64455 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent in center, 30 min test, post infection wk 3 [s] center_time 64457 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent in periphery, 30 min test, post infection wk 3 [s] periphery_time 64459 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of steps included in analysis as measured by DigiGait, post infection day 27, forelimb [n] num_steps_fore 64461 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of steps included in analysis as measured by DigiGait, post infection day 27, hindlimb [n] num_steps_hind 64463 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, forelimb [s] swing_dur_fore 64465 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, hindlimb [s] swing_dur_hind 64467 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, forelimb [%] swing_stride_fore 64469 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, hindlimb [%] swing_stride_hind 64471 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of braking phase as measured by DigiGait, post infection day 27, forelimb [s] brake_dur_fore 64473 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of braking phase as measured by DigiGait, post infection day 27, hindlimb [s] brake_dur_hind 64475 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stride_fore 64477 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stride_hind 64479 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stance_fore 64481 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stance_hind 64483 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of propulsion phase as measured by DigiGait, post infection day 27, forelimb [s] propel_dur_fore 64485 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of propulsion phase as measured by DigiGait, post infection day 27, hindlimb [s] propel_dur_hind 64487 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stride_fore 64489 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stride_hind 64491 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stance_fore 64493 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stance_hind 64495 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, forelimb [%] stance_stride_fore 64497 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, hindlimb [%] stance_stride_hind 64499 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, forelimb [ratio] stance_swing_fore 64501 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, hindlimb [ratio] stance_swing_hind 64503 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, forelimb [s] stride_dur_fore 64505 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, hindlimb [s] stride_dur_hind 64507 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, forelimb [n/s] stride_freq_fore 64509 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, hindlimb [n/s] stride_freq_hind 64511 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_fore 64513 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_hind 64515 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length variability as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_var_fore 64517 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length variability as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_var_hind 64519 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length coefficient of variation as measured by DigiGait, post infection day 27, forelimb [%] stride_length_CV_fore 64521 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length coefficient of variation as measured by DigiGait, post infection day 27, hindlimb [%] stride_length_CV_hind 64523 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_fore 64525 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_hind 64527 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_SD_fore 64529 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_SD_hind 64531 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal paw area as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_max_fore 64533 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal paw area as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_max_hind 64535 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_SD_fore 64537 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_SD_hind 64539 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of forelimb stepping to fore limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, forelimb [ratio] gait_symmetry_fore 64541 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of forelimb stepping to hind limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, hindlimb [ratio] gait_symmetry_hind 64543 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_break_fore 64545 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_break_hind 64547 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_propuls_fore 64549 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_propuls_hind 64551 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, forelimb [cm] overlap_distance_fore 64553 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, hindlimb [cm] overlap_distance_hind 64555 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, forelimb [cm] paw_placement_fore 64557 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, hindlimb [cm] paw_placement_hind 64559 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

gait variability metric as measured by DigiGait, post infection day 27, forelimb ataxia_coefficient_fore 64561 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

gait variability metric as measured by DigiGait, post infection day 27, hindlimb ataxia_coefficient_hind 64563 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] midline_distance_fore 64565 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] midline_distance_hind 64567 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] axis_distance_fore 64569 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] axis_distance_hind 64571 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

perpendicular distance between centroids of either set of axial paws during peak stance as measured by DigiGait, post infection day 27 [cm] stance_width 64573 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stance width coefficient of variation as measured by DigiGait, post infection day 27 [%] stance_width_CV 64575 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of left and right stance durations as measured by DigiGait, post infection day 27 [ratio] stance_factor 64577 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride width variability as measured by DigiGait, post infection day 27 [cm] stride_width_var 64579 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle made between left and right paws as a function of stride length and stance width as measured by DigiGait, post infection day 27 [deg] step_angle 64581 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

step angle variability (standard deviation of step angle for set of strides recorded) as measured by DigiGait, post infection day 27 [deg] step_angle_SD 64583 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

step angle coefficient of variation as measured by DigiGait, post infection day 27 [%] step_angle_CV 64585 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

length of forelimb steps as measured by foot print analysis, post infection [cm] length_fore 64587 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

width of forelimb steps as measured by foot print analysis, post infection [cm] width_fore 64594 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

length of hindlimb steps as measured by foot print analysis, post infection [cm] length_hind 64601 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

width of hindlimb steps as measured by foot print analysis, post infection [cm] width_hind 64608 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

rotarod

Theiler's murine encephalomyelitis virus

time to fall from accelerating rotarod, post infection wk 7 [s] rotarod 64615 trial 1 trial 2 trial 3 trial 4 trial 5 trial 6 trial 7 trial 8 trial 9

CC

5

both

4wks

N=2

2017

JaxCC1

open field test

(none)

whole arena time spent mobile, 20 min test [s] time_mobile_OF 89001

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

whole arena resting time, 20 min test [s] whole_rest_OF 89002

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

whole arena time spent vertical, 20 min test [s] time_vertical_OF 89003

CC

17

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

number of rears, 20 min test [n] rears_OF 89004 1st 5min 2nd 5min 3rd 5min 4th 5min

CC

17

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

total number of rears, 20 min test [n] rears_total_OF 89008

CC

17

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled [cm] distance_OF 89009 1st 5min 2nd 5min 3rd 5min 4th 5min

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

total distance traveled, 20 min test [cm] distance_total_OF 89013

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled habituation ratio, 20 min test [ratio] distance_habit__OF 89014

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled slope, 20 min test distance_slope_OF 89015

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled in center of arena, 20 min test [cm] center_dist_OF 89016

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled in periphery of arena, 20 min test [cm] periphery_dist_OF 89017

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

average speed in center of arena, 20 min test [cm/s] center_speed_OF 89018

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

average speed in periphery of arena, 20 min test [cm/s] periphery_speed_OF 89019

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

whole arena average speed, 20 min test [cm/s] whole_speed_OF 89020

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

number of fecal boli, 20 min test [n] defecation_OF 89025

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

permanence time in periphery of arena, 20 min test [s] periphery_perm_OF 89028

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

permanence time in corners of arena, 20 min test [s] corners_perm_OF 89030

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in corners of arena, 20 min test [s] pct_corners_OF 89031

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in corners, habituation ratio, 20 min test [%] pct_corners_habit_OF 89032

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in corners, slope, 20 min test pct_corners_slope_OF 89033

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

permanence time in center of arena, 20 min test [s] center_perm_OF 89036

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in center of arena, 20 min test [%] pct_center_OF 89038

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in center, habituation ratio, 20 min test [ratio] pct_center_habit_OF 89039

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in center of arena, slope, 20 min test pct_center_slope_OF 89040

CC

18

both

7-9wks

N=7

2018

JaxCC1

body weight

(none)

body weight [g] bw_abr 89046

CC

18

both

15-17wks

N=3

2017

JaxCC1

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 89047 6kHz pip 12kHz pip 18kHz pip 24kHz pip 30kHz pip

CC

18

both

15-17wks

N=3

2017

JaxCC1

hole board test

(none)

number of hole pokes, 20 min test [n] hole_pokes 89056

CC

7

both

8-9wks

N=5

2017

JaxCC1

acoustic startle test

(none)

average acoustic startle response (ASR) evoked by background noise [amplitude] ASR_BN 89061

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average acoustic startle response (ASR), adjusted for background noise [amplitude] ASR 89062 sound pressure level: 74dB 78dB 82dB 120dB

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average percent prepulse inhibition (PPI) evoked by 120 dB, adjusted for background noise [%] PPI 89071 prepulse stimulus: 74dB 78dB 82dB

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average percent prepulse inhibition (PPI) evoked by global prepulse stimulus (74, 78, 82 dB), adjusted for background noise [%] PPI_global 89076

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

maximum slope for percent prepulse inhibition (PPI) averages (74, 78, 82 dB), adjusted for background noise PPI_slope 89078

CC

18

both

9-11wks

N=7

2017

JaxCC1

light-dark box

(none)

latency to enter dark zone, 20 min test [s] reaction_time_LD 89086

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time mobile in light zone, 20 min test [s] light_mobile_LD 89087

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time mobile in dark zone, 20 min test [s] dark_mobile_LD 89088

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time spent in light zone, 20 min test [s] light_dur_LD 89089

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time spent in dark zone, 20 min test [s] dark_dur_LD 89090

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

percentage of total time in light zone, 20 min test [%] pct_light_LD 89091

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

percentage of total time in dark zone, 20 min test [%] pct_dark_LD 89092

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

number of transitions between light and dark zones, 20 min test [n] transitions_LD 89093

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

fecal boli count, 20 min test [n] defecation_LD 89094

CC

18

both

8-10wks

N=7

2017

JaxCC1

body weight

(none)

body weight [g] bw_griptest 89095

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb grip strength [g] front_paws 89096 trial1 trial2 trial3

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb grip strength [g] front_paws_summ 89099 average average normalized to bw

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb and hindlimb grip strength [g] all_paws 89106 trial1 trial2 trial3

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb and hindlimb grip strength [g] all_paws_summ 89109 average average normalized to bw

CC

18

both

7-9wks

N=7

2017

JaxCC1

ECG

(none)

heart rate (beats per min) [n/min] HR 89113

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

heart rate variability, mean of differences between sequential beats (beats per min) [n/min] HR_V 89114

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

heart rate coefficient of variation (signal intensity) [%] HR_CV 89115

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of RR interval [ms] RR 89116

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of PQ interval [ms] PQ 89117

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of PR interval [ms] PR 89118

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of QRS interval [ms] QRS 89119

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of QT interval [ms] QT 89120

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of ST interval [ms] ST 89121

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of QTC interval, calculated by dividing QT interval by square root of preceding RR interval [ms] QTc 89122

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

QT dispersion, measured as inter-lead variability of QT intervals [ms] QT_dispersion 89123

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

QTc dispersion, calculated as rate-corrected QT dispersion [ms] QTc_dispersion 89124

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

mean SR amplitude, mean amplitude of signal measured from signal minimum line to peak of QRS [mV] SR_amplitude 89125

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

mean R amplitude, mean amplitude of signal measured from isoelectric line to peak of QRS [mV] R_amplitude 89126

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

root mean square of successive differences of neighboring RR intervals [ms] rMSSD 89127

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

proportion of number of pairs of successive beat-to-beat intervals that exceed 50 ms (6>ms) [%] pNN50 89128

CC

18

both

10-12wks

N=2

2017

JaxCC1

tail suspension test

(none)

latency to immobility, 5 min test [s] immob_latency_TS 89134

CC

14

both

10-12wks

N=7

2018

JaxCC1

tail suspension test

(none)

duration of immobility, 5 min test [s] immob_duration_TS 89135

CC

14

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

duration [s] duration 89139

CC

18

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

mean duration on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] duration_rota 89141

CC

18

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

learning difference on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] learn_diff_rota 89142

CC

18

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

learning slope on accelerating rotarod (4-40 rpm/5 min) over 5 trials learn_slope_rota 89143

CC

18

both

10-12wks

N=7

2018

JaxCC1

urinalysis

(none)

glucose (urine GLU) [mg/dL] urine_GLU 89151

CC

14

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

magnesium level (urine Mg) [mg/dL] urine_Mg 89152

CC

13

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

creatinine (urine CREA) [mg/dL] CREA 89153

CC

14

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

microalbumin (urine MA), calculated [mg/dL] MA 89154

CC

14

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

albumin-creatinine ratio (urine ACR) [mg/g] ACR 89155

CC

14

both

12-13wks

N=5

2017

JaxCC1

DXA

(none)

percent fat, whole body scan, head excluded [%] pct_fat 89160

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

fat tissue mass, head excluded [g] fat 89161

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

fat tissue mass to body weight ratio [ratio] fat_adj 89162

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

lean tissue mass of whole body scan, head excluded [g] lean 89163

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

lean tissue mass to body weight ratio [ratio] lean_adj 89164

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

total tissue mass, whole body scan, head excluded [g] TTM 89165

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone mineral content of whole body scan, head excluded [g] BMC 89169

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone mineral content to body weight ratio [ratio] BMC_adj 89170

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone mineral density of whole body scan, head excluded [g/cm²] BMD 89171

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone area, whole body, head excluded [cm²] bone_area 89172

CC

18

both

13-15wks

N=7

2017

JaxCC1

body size and weight

(none)

body weight [g] bw_dxa 89173

CC

18

both

13-15wks

N=7

2017

JaxCC1

body size and weight

(none)

body length [cm] body_length 89174

CC

18

both

13-15wks

N=7

2017

JaxCC1

metabolic panel

(none)

total bilirubin (plasma TBIL) [mg/dL] TBIL 89179

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

calcium (plasma Ca) [mg/dL] calcium 89180

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

chloride (plasma Cl) [mmol/L] chloride 89181

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

iron (plasma Fe) [mg/dL] iron 89182

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

phosphorus (plasma phosphate) [mg/dL] phosphate 89183

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

potassium (plasma K) [mmol/L] potassium 89184

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

alkaline phosphatase (plasma ALP) [IU/L] ALP 89185

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

sodium (plasma Na) [mmol/L] sodium 89186

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

alanine transaminase (plasma ALT) [IU/L] ALT 89187

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

aspartate transaminase (plasma AST) [IU/L] AST 89188

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

aspartate transaminase to alanine transaminase ratio (plasma AST:ALT) [ratio] AST_ALT_ratio 89189

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

carbon dioxide (plasma CO₂) [mmol/L] carbon_dioxide 89190

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

glucose (plasma GLU, no fast) [mg/dL] GLU 89191

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

albumin (plasma Alb) [g/L] albumin 89192

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

total protein (plasma TP) [g/L] total_protein 89194

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

blood urea nitrogen (BUN) [mg/dL] urea 89195

CC

18

both

17-19wks

N=5

2017

JaxCC1

lipid profile

(none)

HDL cholesterol (plasma HDL) [mg/dL] HDL 89196

CC

18

both

17-19wks

N=6

2017

JaxCC1

lipid profile

(none)

HDL cholesterol to total cholesterol ratio [ratio] HDL_total_ratio 89197

CC

18

both

17-19wks

N=6

2017

JaxCC1

lipid profile

(none)

total cholesterol (plasma CHOL, no fast) [mg/dL] CHOL 89198

CC

18

both

17-19wks

N=6

2017

JaxCC1

lipid profile

(none)

non-esterified fatty acids (plasma NEFA) [mmol/L] NEFA 89199

CC

18

both

17-19wks

N=5

2017

JaxCC1

lipid profile

(none)

triglyceride (plasma TG, no fast) [mg/dL] TG 89200

CC

18

both

17-19wks

N=6

2017

JaxCC1

hormone quantification

(none)

insulin (plasma) [pg/mL] insulin 89201

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 89206

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

reticulocyte count (Retic; units per volume x 10⁹) [n/µL] Retic 89207

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

reticulocyte differential (percent of total RBC) [%] pct_Retic 89208

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 89209

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

basophil differential (percent of total WBC) [%] pct_BASO 89210

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

eosinophil differential (percent of total WBC) [%] pct_EOS 89211

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

lymphocyte differential (percent of total WBC) [%] pct_LYM 89212

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

monocyte differential (percent of total WBC) [%] pct_MONO 89213

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

neutrophil differential (percent of total WBC) [%] pct_NEUT 89214

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

large unstained cells (percent of total WBC) [%] pct_LUC 89215

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

hematocrit (HCT) [%] HCT 89219

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

measured hemoglobin (mHGB) [g/dL] mHGB 89220

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

calculated hemoglobin (cHGB) [g/dL] cHGB 89221

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

RBC corpuscular hemoglobin concentration mean (CHCM) [g/dL] CHCM 89222

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean corpuscular hemoglobin (CHr) [pg] CHr 89223

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

hemoglobin concentration distribution width (HDW) [g/dL] HDW 89224

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean RBC corpuscular hemoglobin (MCH) [pg] MCH 89225

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 89226

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 89229

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 89230

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] PLT 89231

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 89232

CC

18

both

17-19wks

N=6

2017

JaxCC1

body weight

(none)

body weight [g] bw 89236

CC

18

both

17-19wks

N=6

2017

JaxCC1

organ weights

(none)

heart weight [mg] heart_wt 89237 weight normalized to body weight

CC

18

both

17-19wks

N=6

2017

Lazear1

organ weights

(none)

testis weight (1 testis) [g] testis_wt 63101

CC

12

m

15-22wks

N=2

2018

Lazear1

sperm count

(none)

number of sperm per mL of semen (x 10⁶) [n/mL] sperm_count 63102

CC

10

m

15-22wks

N=2

2018

Lazear1

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 63103

CC

10

m

15-22wks

N=2

2018

Lazear1

microscopy

(none)

percentage of sperm that move in a consistent direction [%] sperm_processive 63104

CC

10

m

15-22wks

N=2

2018

Lazear1

colony observation

(none)

mean litter size after mating with two FVB/NJ females [n] litter_size 63105

CC

10

m

15-22wks

N=1

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD3- [%] CD3_neg 63501

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic CD3- lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_CD3_neg 63502

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_tot 63503

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27- CD11b- [%] CD27_neg_CD11b_neg 63504

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27+ CD11b- [%] CD27_pos_CD11b_neg 63505

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27+ CD11b+ [%] CD27_pos_CD11b_pos 63506

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27- CD11b+ [%] CD27_neg_CD11b_pos 63507

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_NK 63508

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_tot 63509

CC w/par

64

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are T cells [%] T_cells 63515

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522

CC w/par

65

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are plasmacytoid dendritic cells [%] pDC 63523

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are conventional dendritic cells [%] cDC 63524

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are merocytic [%] mDC_of_cDC 63525

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are merocytic dendritic cells [%] mDC_of_tot 63526

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are cDC1 [%] cDC1_of_cDC 63527

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are cDC1 conventional dendritic cells [%] cDC1_of_tot 63528

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are cDC2 [%] cDC2_of_cDC 63529

CC w/par

63

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are cDC2 conventional dendritic cells [%] cDC2_of_tot 63530

CC w/par

63

both

5-8wks

N=2

2018

Mao1

body weight

(none)

body weight [g] bw 54101

CC

16

both

10wks

N=11

2015

Mao1

rotarod

(none)

speed prior to falling off of accelerating rotarod, 20 rpm/min [n/min] speed 54111

CC

16

both

10wks

N=11

2015

McMullan1

colony observation

(none)

age (local parameter) [mo] age_mo 60401

CC

50

f

17-72wks

N=5

2017

McMullan1

body size and weight

(none)

body weight [g] body_wt 60411

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

weight of fat portion of body mass, whole body with head [g] fat_wt 60421

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

percentage of body mass that is fat, whole body with head [%] fat_pct 60422

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

weight of lean portion of body mass, whole body with head [g] lean_wt 60423

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

percentage of body mass that is lean, whole body with head [%] lean_pct 60424

CC

50

f

17-72wks

N=5

2017

McMullan1

treadmill endurance test

(none)

total forced endurance distance [m] endurance 60431

CC

50

f

7-72wks

N=5

2017

McMullan2

running wheel monitoring

(none)

total distance [m] distance 60501 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

CC

42

f

20-88wks

N=4

2017

McMullan2

running wheel monitoring

(none)

total duration [min] duration 60531 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

CC

42

f

20-88wks

N=4

2017

McMullan2

running wheel monitoring

(none)

mean speed [m/min] speed 60561 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

CC

42

f

20-88wks

N=4

2017

McMullan3

colony observation

(none)

age (local parameter) [mo] age_mo 60601

CC

43

f

20-88wks

N=4

2017

McMullan3

body weight

(none)

body weight [g] body_wt 60611 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

percentage of body mass that is fat [%] fat 60621 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

percentage of body mass that is lean [%] lean 60631 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

body weight

(none)

body weight response [%] body_wt_start 60641 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

fat mass response [%] fat_start 60651 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

lean mass response [%] lean_start 60661 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

intake monitoring

(none)

food intake [g] food_start 60671 start to 2 wks 2 wks to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan4

body weight

(none)

body weight at start of experiment [g] bw_start 61301 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

body weight

exercise

body weight after 2 wks of treatment [g] bw_end 61306 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

body weight

exercise

body weight, response after 2 wks of treatment [%] bw_resp 61311 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

(none)

percentage of body mass that is fat at start of experiment [%] fat_start 61316 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is fat after 2 wks of treatment [%] fat_end 61321 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is fat, response after 2 wks of treatment [%] fat_resp 61326 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

(none)

percentage of body mass that is lean at start of experiment [%] lean_start 61331 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is lean after 2 wks of treatment [%] lean_end 61336 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is lean, response after 2 wks of treatment [%] lean_resp 61341 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

running wheel monitoring

exercise

mean total daily distance for days 11-12 of wheel access [km] distance 61346

CC

13

f

32-40wks

N=7

2018

McMullan4

running wheel monitoring

exercise

mean total daily duration for days 11-12 of wheel access [min] duration 61351

CC

13

f

32-40wks

N=7

2018

McMullan4

running wheel monitoring

exercise

mean daily speed for days 11-12 of wheel access [m/min] speed 61356

CC

13

f

32-40wks

N=7

2018

McMullan4

intake monitoring

exercise

total food intake over 2 wks of wheel access [g] food 61361

CC

13

f

32-40wks

N=7

2018

McMullan4

intake monitoring

exercise

total food intake over 2 wks of wheel access adjusted to bw_start [ratio] food_adj 61366

CC

13

f

32-40wks

N=7

2018

McMullan6

body weight

(none)

body weight at start of experiment [g] bw_start 61501 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

body weight

exercise

body weight at after 4 wks of treatment [g] bw_end 61506 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

body weight

exercise

body weight, response to 4 wks of treatment [%] bw_resp 61511 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

(none)

percentage of body mass that is fat at start of experiment [%] fat_start 61516 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is fat after 4 wks of treatment [%] fat_end 61521 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is fat, response after 4 wks of treatment [%] fat_resp 61526 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

(none)

percentage of body mass that is lean at start of experiment [%] lean_start 61531 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is lean after 4 wks of treatment [%] lean_end 61536 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is lean, response after 4 wks of treatment [%] lean_resp 61541 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean oxygen consumption at start of experiment, during day [mL/h] VO2_d_start 61601 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean oxygen consumption after 4 wks of treatment, during day [mL/h] VO2_d_end 61604 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean oxygen consumption at start of experiment, during night [mL/h] VO2_n_start 61607 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean oxygen consumption after 4 wks of treatment, during night [mL/h] VO2_n_end 61611 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean carbon dioxide production at start of experiment, during day [mL/h] VCO2_d_start 61614 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean carbon dioxide production after 4 wks of treatment, during day [mL/h] VCO2_d_end 61617 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean carbon dioxide production at start of experiment, during night [mL/h] VCO2_n_start 61621 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean carbon dioxide production after 4 wks of treatment, during night [mL/h] VCO2_n_end 61624 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean respiratory exchange rate at start of experiment, during day [ratio] RER_d_start 61627 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean respiratory exchange rate after 4 wks of treatment, during day [ratio] RER_d_end 61631 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean respiratory exchange rate at start of experiment, during night [ratio] RER_n_start 61634 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean respiratory exchange rate after 4 wks of treatment, during night [ratio] RER_n_end 61637 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

activity (beam breaks) at start of experiment, during day [n] act_d_start 61641 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

activity (beam breaks) after 4 wks of treatment, during day [n] act_d_end 61644 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

activity (beam breaks) at start of experiment, during night [n] act_n_start 61647 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

activity (beam breaks) after 4 wks of treatment, during night [n] act_n_end 61651 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean heat production at start of experiment, during day [kcal/h/kg] heat_d_start 61654 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean heat production after 4 wks of treatment, during day [kcal/h/kg] heat_d_end 61657 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean heat production at start of experiment, during night [kcal/h/kg] heat_n_start 61661 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean heat production after 4 wks of treatment, during night [kcal/h/kg] heat_n_end 61664 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total food intake at start of experiment, during day [g] food_d_start 61667 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total food intake after 4 wks of treatment, during day [g] food_d_end 61671 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total food intake at start of experiment, during night [g] food_n_start 61674 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total food intake after 4 wks of treatment, during night [g] food_n_end 61677 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total water intake at start of experiment, during day [mL] water_d_start 61681 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total water intake after 4 wks of treatment, during day [mL] water_d_end 61684 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total water intake at start of experiment, during night [mL] water_n_start 61687 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total water intake after 4 wks of treatment, during night [mL] water_n_end 61691 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

Molenhuis1

monitoring system

(none)

social interaction (time exploring unfamiliar conspecific mouse), 2 min interval [s] social_time 110068

CC

52

m

7-20wks

N=5

2018

Molenhuis1

monitoring system

(none)

social discrimination capacity (preference for novel versus familiar conspecific mouse) [ratio] discrimination 110069 short term discrimination long term discrimination

CC

49

m

7-20wks

N=4

2018

Molenhuis1

monitoring system

(none)

distance traveled with four novel objects, 10 min test [cm] distance 110071

CC

52

m

7-20wks

N=6

2018

Molenhuis1

monitoring system

(none)

time spent digging with four novel objects, 10 min test [s] digging 110072

CC

52

m

7-20wks

N=5

2018

Molenhuis1

monitoring system

(none)

time spent grooming with four novel objects, 10 min test [s] grooming 110073

CC

52

m

7-20wks

N=5

2018

Molenhuis1

body weight

(none)

body weight [g] bw 110074

CC

51

m

7-20wks

N=6

2018

Molenhuis1

organ weights

(none)

brain weight [g] brain_wt 110075

CC

52

m

7-20wks

N=5

2018

Shorter4

body weight

(none)

body weight [g] bw 110093

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

testis weight [g] testis 110094 left right

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

testis weight mean [g] testis_mean 110096

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

testis weight as a percentage of body weight [%] testis_pct_bw 110097

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

epididymis plus vas deferens weight [g] epidid_vd 110098 left right

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

epididymis plus vas deferens weight mean [g] epidid_vd_mean 110100

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

epididymis plus vas deferens weight as a percentage of body weight [%] epidid_vd_pct_bw 110101

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

seminal vesicles weight total [g] semin_vesi_tot 110102

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

seminal vesicles weight as a percentage of body weight [%] semin_vesi_pct_bw 110103

CC

12

m

15-33wks

N=3

2019

Shorter4

sperm count

(none)

sperm count per mouse (x 10⁶) [n] sperm_count 110104

CC

12

m

15-33wks

N=3

2019

Shorter4

sperm count

(none)

sperm count per mg testis weight (x 10³) [n/mg] sperm_adj 110105

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of sperm that are motile [%] motile 110106 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] vigorous 110108 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] hyper 110110 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

sperm mean curvilinear velocity [µm/s] VCL 110112 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with normal morphology [%] normal_sperm 110114

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with abnormal head shape [%] abnormal_head 110115

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with abnormal tail bending [%] abnormal_tail 110116

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with broken tails [%] broken_tail 110117

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 65601 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 65606 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 65611 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 65616 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 65621 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 65626 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 65631 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 65636 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 65641 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 65646 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 65651 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 65656 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean straightness [ratio] sperm_STR 65661 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean linearity [ratio] sperm_LIN 65666 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 1, core fucose with 1 GlcNAc antenna (relative abundance) [%] gp1 110006

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 2, composition not determined (relative abundance) [%] gp2 110007

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 3, composition not determined (relative abundance) [%] gp3 110008

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 4, core fucose with 2 GlcNAc antennae (relative abundance) [%] gp4 110009

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 5, composition not determined (relative abundance) [%] gp5 110010

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 6, core fucose with bisecting GlcNAc and 2 GlcNAc antennae (relative abundance) [%] gp6 110011

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 7, composition not determined (relative abundance) [%] gp7 110012

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 8, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,6-linked core mannose (relative abundance) [%] gp8 110013

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 9, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,3-linked core mannose (relative abundance) [%] gp9 110014

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 10, core fucose with bisecting GlcNAc and 2 GlcNAc antennae, 1 galactose linked to alpha1,6-linked core mannose (relative abundance) [%] gp10 110015

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 11, composition not determined (relative abundance) [%] gp11 110016

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 12, composition not determined (relative abundance) [%] gp12 110017

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 13, composition not determined (relative abundance) [%] gp13 110018

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 14, core fucose with 2 GlcNAc antennae, 2 galactoses (relative abundance) [%] gp14 110019

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 15, composition not determined (relative abundance) [%] gp15 110020

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 16, composition not determined (relative abundance) [%] gp16 110021

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 17a, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,6-linked core mannose, 1 sialic acid (relative abundance) [%] gp17a 110022

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 17b, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,3-linked core mannose, 1 sialic acid (relative abundance) [%] gp17b 110023

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 18, composition not determined (relative abundance) [%] gp18 110024

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 19, composition not determined (relative abundance) [%] gp19 110025

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 20, core fucose with 2 GlcNAc antennae, 2 galactoses, 1 sialic acid (relative abundance) [%] gp20 110026

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 21, composition not determined (relative abundance) [%] gp21 110027

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 22, composition not determined (relative abundance) [%] gp22 110028

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 23, core fucose with 2 GlcNAc antennae, 3 galactoses, 1 sialic acid (relative abundance) [%] gp23 110029

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 24, composition not determined (relative abundance) [%] gp24 110030

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 25, core fucose with 2 GlcNAc antennae, 2 galactoses, 2 sialic acids (relative abundance) [%] gp25 110031

CC

111

both

4-140wks

N=3

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with bisected N-acetylglucosamine N-glycan structures (relative abundance) [%] mIgG1_B 110032

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with galactosylated N-glycan structures (relative abundance) [%] mIgG1_G 110033

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with agalactosylated N-glycan structures (relative abundance) [%] mIgG1_G0 110034

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with monogalactosylated N-glycan structures (relative abundance) [%] mIgG1_G1 110035

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with digalactosylated N-glycan structures (relative abundance) [%] mIgG1_G2 110036

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with sialylated N-glycan structures (relative abundance) [%] mIgG1_S 110037

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with monosialylated N-glycan structures (relative abundance) [%] mIgG1_S1 110038

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with disialylated N-glycan structures (relative abundance) [%] mIgG1_S2 110039

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with alpha1,3-linked galactose residue N-glycan structures (relative abundance) [%] mIgG1_aGal 110040

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with bisected N-acetylglucosamine N-glycan structures (relative abundance) [%] mIgG2_B 110041

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with galactosylated N-glycan structures (relative abundance) [%] mIgG2_G 110042

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with agalactosylated N-glycan structures (relative abundance) [%] mIgG2_G0 110043

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with monogalactosylated N-glycan structures (relative abundance) [%] mIgG2_G1 110044

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with digalactosylated N-glycan structures (relative abundance) [%] mIgG2_G2 110045

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with sialylated N-glycan structures (relative abundance) [%] mIgG2_S 110046

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with monosialylated N-glycan structures (relative abundance) [%] mIgG2_S1 110047

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with disialylated N-glycan structures (relative abundance) [%] mIgG2_S2 110048

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with alpha1,3-linked galactose residue N-glycan structures (relative abundance) [%] mIgG2_aGal 110049

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with bisected N-acetylglucosamine N-glycan structures (relative abundance) [%] mIgG3_B 110050

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with galactosylated N-glycan structures (relative abundance) [%] mIgG3_G 110051

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with agalactosylated N-glycan structures (relative abundance) [%] mIgG3_G0 110052

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with monogalactosylated N-glycan structures (relative abundance) [%] mIgG3_G1 110053

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with digalactosylated N-glycan structures (relative abundance) [%] mIgG3_G2 110054

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with sialylated N-glycan structures (relative abundance) [%] mIgG3_S 110055

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with monosialylated N-glycan structures (relative abundance) [%] mIgG3_S1 110056

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with disialylated N-glycan structures (relative abundance) [%] mIgG3_S2 110057

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with alpha1,3-linked galactose residue N-glycan structures (relative abundance) [%] mIgG3_aGal 110058

CC

95

both

20-117wks

N=2

2018

Filter Table Results